Pain: Clinical Trials

2,050 trials for Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1280 completed, 250 unknown, 196 terminated, 125 recruiting. 2050 Phase 2, 309 Phase 3, 244 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22050Completed 1280, Unknown 250, Terminated 196, Recruiting 125, Withdrawn 101, Not yet recruiting 53, Active not recruiting 26, Suspended 10, Enrolling by invitation 9
Phase 3309Completed 185, Unknown 55, Recruiting 21, Terminated 18, Withdrawn 12, Not yet recruiting 8, Enrolling by invitation 5, Active not recruiting 4, Suspended 1
Phase 1244Completed 150, Unknown 33, Recruiting 16, Withdrawn 14, Terminated 13, Not yet recruiting 10, Active not recruiting 6, Enrolling by invitation 1, Suspended 1

Follow Pain: new trials by email Literature Review of Pain trials Research Report on Pain

Trials (filtered) newest first · largest first

All 2,050 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine and Midazolam Infusions for CRPS: Feasibility Study
Ketamine, Midazolam, Normal Saline - Complex Regional Pain Syndromes
Phase 2WithdrawnStanford University2099-01-012024-11-22
Efficacy and Safety of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
Gene Therapy GNSC-001, Placebo - Knee Arthritis Osteoarthritis, Knee Arthritis, Osteoarthritis
Phase 2 / Phase 3Not yet recruitingGenascence Corporation2402027-07-012026-09-21
Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain
AFA-281 - Lumbosacral Radiculopathy
Phase 2Not yet recruitingAfasci Inc4082027-04-012025-06-26
Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE)
Exercise, Duloxetine, Placebo - Knee Osteoarthritis, Pain
Phase 2Not yet recruitingVA Office of Research and Development1022027-03-012026-06-16
Semaglutide for Low Back Pain
Semaglutide (administered by PDS290 pen-injector), Placebo (administered by PDS290 pen-injector) - Lower Back Pain, Obesity (BMI>30)
Phase 2Not yet recruitingWashington University School of Medicine2502027-02-012026-07-28
Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patients With Endometriosis
Desloratadine, Placebo - Endometriosis, Endometriosis (Diagnosis)
Phase 2Not yet recruitingMedical University of Vienna602027-02-012026-09-18
PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates
Teverelix DP, Teverelix DP Placebo - Endometriosis Pelvic, Endometriosis Ovaries
Phase 2Not yet recruitingAntev Ltd.842027-02-012026-11-03
Regenerative Medicine for Joint Hypermobility and Instability
Dextrose 20% Prolotherapy, Autologous Platelet-Rich Plasma, Doxycycline Hyclate Injectable (Investigational) - Ehlers-Danlos Syndrome Hypermobility Type (hEDS), Ehlers-Danlos Syndrome (EDS)
Phase 1 / Phase 2Not yet recruitingManhattan Pain Medicine, PLLC1002027-01-152026-10-06
Dexmedetomidine for Invasive Ventilation In the NEOnate
Dexmedetomidine Injectable Solution, Glucose 5% Injectable Solution - Invasive Ventilation, Infant Pain
Phase 2 / Phase 3Not yet recruitingCentre Hospitalier Intercommunal Creteil2462027-01-012026-08-26
Safety of F14 Following Total Knee Replacement
F14 (sustained release celecoxib) - Analgesia
Phase 2 / Phase 3SuspendedArthritis Innovation Corporation1002027-01-012026-06-05
CBD Supplementation in Brazilian Jiu-Jitsu Athletes
CBD Isolate 100mg BID, Placebo - Pro and Anti Inflamatory Cytokines, Pain
Phase 2 / Phase 3Not yet recruitingAssociação Pan-Americana Multidisciplinar de Endocanabinologia1002027-01-012026-07-27
Efficacy of Botulinum Toxin Versus Placebo on Pain and Health Related Quality of Life of Patients With Piriformis Muscle Syndrome
Botulinum Toxin - A injections, Placebo - Piriformis Muscle Syndrome
Phase 2Not yet recruitingCentre Hospitalier Universitaire de Nīmes1082027-01-012026-10-21
Visual Instillation of Sphenopalatine-block Intervention for ONgoing Migraine
Topical solution of 4% lidocaine, Saline 0.9% - Migraine, Facial Pain or Pressure
Phase 2Not yet recruitingAssociation of Migraine Disorders742027-01-012026-11-09
Efficacy of Intravenous Oxytocin to Speed Recovery After THA
intravenous administration of oxytocin, Placebo - Total Hip Arthroplasty
Phase 2Enrolling by invitationWake Forest University Health Sciences802026-12-012026-10-23
Allopregnanolone in Chronic Complex Traumatic Brain Injury
Placebo, Allopregnanolone - Traumatic Brain Injury (TBI)
Phase 2Not yet recruitingVA Office of Research and Development1322026-12-012026-10-19
Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial
Pregnenolone, DHEA, Placebo - Chronic Low Back Pain
Phase 2Not yet recruitingVA Office of Research and Development1082026-12-012026-09-08
3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
3D1002 (50 mg)(Phase IIa), 3D1002 (100 mg)(Phase IIa), 3D1002 (150 mg)(Phase IIa) - Cancer Pain
Phase 2Not yet recruiting3D Medicines1772026-12-012026-03-11
Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression
Ketamine hydrochloride injection - Treatment Resistant Depression (TRD), Chronic Pain
Phase 2Not yet recruitingUniversity of Rochester252026-12-012026-09-24
MMA Infusion of Lidocaine for Treatment of Headache in Patients With Aneurysmal SAH
Lidocaine hydrochloride, Isotonic saline - Headaches Associated With Subarachnoid Hemorrhage (SAH)
Phase 2Not yet recruitingCopenhagen University Hospital, Rigshospitalet902026-12-012026-09-11
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
Resiniferatoxin - Intractable Pain, Palliative Care
Phase 1 / Phase 2Not yet recruitingNational Institute of Neurological Disorders and Stroke (NINDS)302026-11-272026-10-29

Showing 20 of 2050. Sign in to see all of them.

Narrower conditions

Pain, Postoperative (398)  ·  Chronic Pain (187)  ·  Neuralgia (174)  ·  Agnosia (124)  ·  Acute Pain (111)  ·  Low Back Pain (110)  ·  Headache (77)  ·  Osteoarthritis (69)  ·  Neuralgia, Postherpetic (68)  ·  Angina Pectoris (51)  ·  Migraine Disorders (51)  ·  Neoplasms (51)  ·  Osteoarthritis, Knee (51)  ·  Abdominal Pain (47)

Broader conditions

Neurologic Manifestations (2050)  ·  Pathological Conditions, Signs and Symptoms (2050)  ·  Signs and Symptoms (2049)  ·  Nervous System Diseases (611)  ·  Pathologic Processes (579)  ·  Postoperative Complications (406)  ·  Neuromuscular Diseases (344)  ·  Musculoskeletal Diseases (283)  ·  Peripheral Nervous System Diseases (257)  ·  Joint Diseases (162)  ·  Neurobehavioral Manifestations (140)  ·  Mental Disorders (134)  ·  Rheumatic Diseases (133)  ·  Cardiovascular Diseases (131)

Interventions

Bupivacaine (98)  ·  Lidocaine (70)  ·  Saline Solution (69)  ·  Morphine (67)  ·  Acetaminophen (58)  ·  Sodium Chloride (56)  ·  Ketamine (43)  ·  Pregabalin (39)  ·  Dexmedetomidine (37)  ·  Ibuprofen (36)  ·  Ropivacaine (31)  ·  Fentanyl (30)  ·  Dexamethasone (27)  ·  Dronabinol (23)  ·  Botulinum Toxins, Type A (22)

Sponsors

Assiut University (49)  ·  Pfizer (26)  ·  Wake Forest University Health Sciences (19)  ·  Mayo Clinic (17)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (17)  ·  Pacira Pharmaceuticals, Inc (17)  ·  University Hospital, Clermont-Ferrand (17)  ·  Cairo University (16)  ·  Montefiore Medical Center (14)  ·  University of Florida (13)  ·  AstraZeneca (12)  ·  GlaxoSmithKline (12)  ·  Johns Hopkins University (12)  ·  VA Office of Research and Development (12)  ·  Heron Therapeutics (11)

Countries

United States (996)  ·  Canada (148)  ·  Egypt (108)  ·  Germany (86)  ·  France (81)  ·  United Kingdom (79)  ·  Spain (68)  ·  Poland (64)  ·  China (57)  ·  Denmark (54)  ·  Brazil (50)  ·  Italy (42)  ·  Australia (41)  ·  Israel (39)  ·  Czechia (37)

Top investigators

David Prior (6)  ·  Hala S Abdel-Ghaffar, MD (5)  ·  James C Eisenach, MD (5)  ·  James C. Eisenach, M.D. (5)  ·  Adeel Riaz, MD (4)  ·  Bror Jonzon (4)

Results publications

PMID 22900785, PMID 36729473, PMID 37523477, PMID 17825712, PMID 17877825, PMID 21079055, PMID 22212857, PMID 22510183, PMID 22792007, PMID 22795280, PMID 26112278, PMID 26554876, PMID 27720917, PMID 27747583, PMID 27893109, PMID 28159728, PMID 30737315, PMID 32871021, PMID 33675631, PMID 34532852, PMID 37530822, PMID 10353500, PMID 10506634, PMID 10613619, PMID 10772585, PMID 11027905, PMID 11145807, PMID 11323325, PMID 11387363, PMID 11402097, PMID 11554951, PMID 11576800, PMID 11853818, PMID 12145072, PMID 12148679, PMID 12221344, PMID 12384756, PMID 12779107, PMID 12807853, PMID 12873949, PMID 12897484, PMID 12907905, PMID 1349061, PMID 14665993, PMID 14701781, PMID 15030944, PMID 15115710, PMID 1517644, PMID 15230906, PMID 15234492

NIH funding

2019 (12), 2008 (10), 2009 (9), 2014 (8), 2018 (8), 2016 (7), 2015 (6), 2017 (5), 2023 (5), P01NS119159 (5), 2025 (3), P01NS041386 (3), P30CA015083 (3), 2004 (2), 2005 (2)